Intensive Outpatient Treatment for Suicidal Veterans

Suicidality Clinical Trial

— CAMS  

Official title:

Intensive Outpatient Treatment for Suicidal Veterans: A Randomized Clinical Trial and Feasibility Investigation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01334372
• Other study ID #: 06-1058
• Status: Completed
• Phase: N/A
• First received: April 11, 2011
• Last updated: April 12, 2011
• Start date: February 2007

Study information

• Verified date: April 2011
• Source: VA Eastern Colorado Health Care System
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

This investigation is a feasibility study conducted in a VA outpatient treatment setting. The study is designed to test the feasibility of implementing a novel way of working with suicidal patients, the Collaborative Assessment and Management of Suicidality (CAMS). The primary purpose of the proposed project is to determine if it is possible to train clinicians working in the Mental Health Clinic at the Denver VA Medical Center (VAMC) to utilize this therapeutic framework. This project is extremely timely in relation to expectations of future increased clinical demands among potentially high-risk Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) veterans who may become suicidal in the years to come.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 48
• Est. primary completion date: December 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 89 Years

Eligibility

Inclusion Criteria:

1. Suicidality endorsed during the regular Mental Health intake interview or at the time of admission.

2. Over the age of 18 years.

3. New or returning patients to the VA MHC.

4. Living within the larger Denver metropolitan region during the duration of the treatment.

5. Willing to travel to the ECHCS Denver VAMC at times other than scheduled therapy appointments to complete follow-up assessment measures.

Exclusion Criteria:

1. Psychosis that would interfere with an individual's ability to provide informed consent.

2. Imminent suicidality with the need for immediate psychiatric hospitalization, as defined above in the Background section, at the time of MH intake.

3. Current involuntary status for psychiatric hospitalization.

4. Inability to adequately respond to questions regarding the informed consent procedure. See Special Consent Issues section below.

Study Design

N/A

Related Conditions & MeSH terms

• Suicidality

Intervention

Behavioral:
• CAMS
First, as discussed above, suicidality is the focus of treatment rather than one of many symptoms being treated. Second is the emphasis on patient and therapist collaborating on treatment rather than the therapist dictating how therapy progresses. Beyond those two basic tenets, each therapist is free to utilize their current clinical skills to conduct psychotherapy.

Locations

Country	Name	City	State
United States	Visn 19 Mirecc	Denver	Colorado

Sponsors (3)

Lead Sponsor	Collaborator
VA Eastern Colorado Health Care System	The Catholic University of America, VA Office of Research and Development

Country where clinical trial is conducted

United States,